Patient Navigation Program Increases Receipt of Colonoscopy
By Elana Gotkine HealthDay Reporter
THURSDAY, April 3, 2025 -- A patient navigation program is effective for increasing receipt of follow-up colonoscopy among adults with an abnormal stool test result, according to a study published online April 1 in the Annals of Internal Medicine.
Gloria D. Coronado, Ph.D., from the Kaiser Permanente Center for Health Research in Portland, Oregon, and colleagues conducted a randomized controlled trial at 32 clinics in a federally qualified health center in Washington state to examine whether a six-topic, telephone-based patient navigation program delivered to persons with an abnormal stool test result increased follow-up colonoscopy completion at one year. Participants were aged 50 to 75 years with an abnormal fecal test result in the previous month; the primary intention-to-treat analysis included 967 patients: 479 in patient navigation and 488 in usual care.
The researchers found that the patient navigation group had higher receipt of follow-up colonoscopy than the usual care group (55.1 versus 42.1 percent). Patients' probability of obtaining a colonoscopy without navigation did not moderate the intervention effect.
"Patient navigation improved rates of colonoscopy follow-up after abnormal fetal immunochemical testing results among patients at a large federally qualified health clinic," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
Outcomes With Immune Checkpoint Inhibitors Similar for Older, Younger Patients
TUESDAY, April 29, 2025 -- Patients with cancer aged 65 years and older receiving immune checkpoint inhibitors (ICIs) derive similar clinical outcomes as younger patients...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.